information September, 2007 1
2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
September, 2007 3
2007 4 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
α September, 2007 5
6 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
September, 2007 7
8 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
ä ä September, 2007 9
ä 8:559:00 9:009:50 1 S1-1S1-5 9:5010:40 2 S2-1S2-6 10:4011:30 Mechanisms of sensitivity and resistance to SP1 EGFR targeted therapies in Lung Cancer Pasi A. Jänne 12:1013:10 1 L1 13:2013:50 2 Optimal Use of EGFR L2 tyrosine kinase inhibitors in 2007 Pasi A. Jänne 13:5014:50 1 W1-1W1-4 14:5015:40 3 S3-1S3-5 15:4016:30 4 S4-1S4-5 16:3017:20 5 S5-1S5-6 17:3519:05 9:009:50 6 S6-1S6-6 9:5011:50 SY-1SY-6 12:1013:10 3 ASCO 2007 Feedback - focus on Biomarker L3 and molecular targeted agent - Giorgio Scagliotti 4 L4 13:2014:40 2 W2-1W2-6 14:4015:30 7 S7-1S7-6 15:3016:30 8 S8-1S8-7 16:3018:00 1 P1-1P1-7 18:0018:20 2 P2-1P2-6 3 P3-1P3-6 4 P4-1P4-5 5 P5-1P5-6 6 P6-1P6-5 7 P7-1P7-6 8 P8-1P8-6 9 P9-1P9-8 10 P10-1P10-7 11 P11-1P11-7 10 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
κ September, 2007 11
α α 12 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
κ β σ September, 2007 13
β α α 14 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
β September, 2007 15
κ 16 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
September, 2007 17
ä 18 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
September, 2007 19
Special Lecture ä 20 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
21 September, 2007 Symposium
Workshop 1 22 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
September, 2007 23
Workshop 2 24 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
September, 2007 25
Session 1 κ κ κκ κ κ 26 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
27 September, 2007
Session 2 28 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
α α α α September, 2007 29
Session 3 β 30 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
September, 2007 31
Session 4 α α α α αα α 32 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
33 September, 2007 α α α α α
Session 5 κ κκ 34 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
35 September, 2007 Session 6
36 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
37 September, 2007 β κκ Session 7
38 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
39 September, 2007 Session 8
40 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
41 September, 2007 α α α α Poster Session
Poster Session 42 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
43 September, 2007 αβ β β Poster Session
Poster Session 44 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
45 September, 2007 α α α α α α α Poster Session
Poster Session κ κ κ 46 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
47 September, 2007 β γ γ Poster Session
Poster Session 48 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
49 September, 2007 αβγδ δ Poster Session
Poster Session 50 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
51 September, 2007 µ β β µ µ µ γ Poster Session
52 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
September, 2007 53
54 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11
September, 2007 55
56 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11